The University of Utah Hospital is a research and teaching hospital on the campus of the University of Utah in Salt Lake City, Utah. It serves as a major regional referral center for Utah and the surrounding states of Idaho, Nevada, Wyoming, Montana and New Mexico.

There are 425 beds in University of Utah Hospitals & Clinics.

During the past decade, University of Utah Hospitals & Clinics conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Utah Hospitals & Clinics" #1 sponsor was "Pfizer" with 4 trials, followed by "Aeglea Biotherapeutics" with 1 trials sponsored, "Chiesi Farmaceutici S.p.A." with 1 trials sponsored, "Debiopharm International SA" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Utah Hospitals & Clinics" #1 collaborator was "Caris Life Sciences" with 1 trials as a collaborator, "Optimal Research (Just In Time sites)" with 1 trials as a collaborator and "Respivant Sciences Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of Utah Hospitals & Clinics" are "Fabry Disease" (2 trials), "Psoriatic Arthritis" (2 trials), "Adult Solid Tumor" (1 trials), "Arginase I Deficiency" (1 trials) and "Arthritis, Psoriatic" (1 trials). Many other conditions were trialed in "University of Utah Hospitals & Clinics" in a lesser frequency.

Most popular intervention types in "University of Utah Hospitals & Clinics" are "Drug" (9 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Tofacitinib" (2 trials), "Adalimumab" (1 trials), "Debio 1347" (1 trials) and "Entrectinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Utah Hospitals & Clinics" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Utah Hospitals & Clinics". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University of Utah Hospitals & Clinics, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Utah Hospitals & Clinics, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".